| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.008 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | -0.085 | 0.008 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.01 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.01 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.077 | 0.01 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.077 | 0.01 |